ResearcherSichuan UniversityActive in the last 2 years

Lin Jiao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-5861-2585; OpenAlex author ID A5101728615. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 2

TRIM21-mediated METTL3 degradation promotes PDAC ferroptosis and enhances the efficacy of Anti-PD-1 immunotherapy. Co-author DOI 10.1038/s41419-025-07550-y ↗
Autophagy-mediated negative feedback attenuates the oncogenic activity of YAP in pancreatic cancer. Last author DOI 10.7150/ijbs.61795 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Wenhao Mao · 2 shared papers, 2021–2025 · strength 0.39
- Paper TRIM21-mediated METTL3 degradation promotes PDAC ferroptosis and enhances the efficacy of Anti-PD-1 immunotherapy. DOI 10.1038/s41419-025-07550-y ↗
- Paper Autophagy-mediated negative feedback attenuates the oncogenic activity of YAP in pancreatic cancer. DOI 10.7150/ijbs.61795 ↗
Ting Sun · 2 shared papers, 2021–2025 · strength 0.39
- Paper TRIM21-mediated METTL3 degradation promotes PDAC ferroptosis and enhances the efficacy of Anti-PD-1 immunotherapy. DOI 10.1038/s41419-025-07550-y ↗
- Paper Autophagy-mediated negative feedback attenuates the oncogenic activity of YAP in pancreatic cancer. DOI 10.7150/ijbs.61795 ↗
Jia Mai · 1 shared paper, 2021 · strength 0.15
- Paper Autophagy-mediated negative feedback attenuates the oncogenic activity of YAP in pancreatic cancer. DOI 10.7150/ijbs.61795 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.